Bingjie Wang, Mengzhe Cai, Luyi Chai, Qiang Xie: Integrated gene expression profiling identifies key molecular drivers and a predictive signature for malignant transformation of oral lichen planus to squamous cell carcinoma. Am J Cancer Res 2026;16(5):1696-1712. (Full text, PDF)
Hui Lan, Yannong Ding, Min Liu: A study comparing the efficacy of R-CHOP and R-DA-EPOCH regimens in young, high-risk treatment-naïve diffuse large B-cell lymphoma patients: a multicenter retrospective analysis. Am J Cancer Res 2026;16(5):1713-1728. (Full text, PDF)
Nan Liu, Ye-Ting Cui, Yi Zheng, Shu-Min Fang, Li-Xi Liao, Ting-Ting Luo, Ze-Hui Zhong, Xiao-Yu Hu, Ming-Hui Zhou, Yan-Yang Tu: Curcumin induces ferroptosis in ovarian cancer cells through the Nrf2/GPX4 regulation axis. Am J Cancer Res 2026;16(5):1729-1744. (Full text, PDF)
Kai Zhao, Jiayu Wei, Ying Shen, Anqi Jiang, Mingyang Gu, Jianzhong Deng: GTPBP4 promotes colorectal cancer cell proliferation by positively regulating MYC-driven glycolytic metabolism. Am J Cancer Res 2026;16(5):1745-1760. (Full text, PDF)
Lei Wang, Mengxiao Wang, Weixiang Qi, Dan Ou, Lu Cao, Rong Cai, Cheng Xu, Shubei Wang, Jiayi Chen, Gang Cai: Survival outcomes in patients with metachronous breast cancer bone metastasis: an 11-year single-institution retrospective study. Am J Cancer Res 2026;16(5):1761-1775. (Full text, PDF)
Yingxin Zhang: Paeonol inhibits prostate cancer progression via the miR-145-5p/GOLM1 axis. Am J Cancer Res 2026;16(5):1776-1790. (Full text, PDF)
Lusine Yaghjyan, Yujing J Heng, Yaileen D Guzman-Arocho, Graham Colditz, Brian Sardella, Ann Fu, Krishna Patel, Bernard Rosner, Maisey Ratcliffe, Rulla M Tamimi: Reliability of stromal markers multiplex immunofluorescent staining: pathologist assessment compared to quantitative image analysis. Am J Cancer Res 2026;16(5):1791-1804. (Full text, PDF, Supplementary Data)
Bo Hou, Yu Zhang: Comparative efficacy of CDK4/6 inhibitors palbociclib, ribociclib, and abemaciclib in HR+/HER2- advanced breast cancer. Am J Cancer Res 2026;16(5):1805-1816. (Full text, PDF)
Ya-Ping Shen, Chun-Hui Zhou, Yan-Huang Huang, Jing Chen: Sequential triple primary malignancies in the larynx, lung, and liver with discordant p53 expression patterns: a case report. Am J Cancer Res 2026;16(5):1817-1822. (Full text, PDF)
Yunxia Wang, Yu Yu, Yongling Pei, Jiayao Wang, Linye Hua, Minjie Li, Yamei Li: Regulatory T cells in the breast cancer tumor microenvironment: new mechanisms, potential therapeutic strategies and future perspectives. Am J Cancer Res 2026;16(5):1823-1846. (Full text, PDF)
Muhammad Naeem, Nan Wu, Liman Cao, Yang Wu, Ren Jing, Yuanbin Luo, Shijian Yi: Unravelling SLC7 family members in thyroid cancer and translational barriers. Am J Cancer Res 2026;16(5):1847-1863. (Full text, PDF)
Imran Kazmi, Shakilur Rahman, Muhammad Afzal, Mohammed Al-Zharani, Fahd A Nasr, Sami I Alzarea, Tarique Hussain Ashraf, Hisham N Altayb, Shoaeb Mohammad Syed, Ghulam Md Ashraf: Molecular carcinogenesis and genetic insights in leiomyosarcoma: involvement of PI3K/AKT/mTOR/MAPK/ERK pathway. Am J Cancer Res 2026;16(5):1864-1882. (Full text, PDF)
Shuaikui Zheng, Xiaocai Zheng, Zhanwei Li: Establishment and validation of a 28-day clinical outcome prediction model for acute promyelocytic leukemia based on an early platelet-coagulation factor combined transfusion strategy. Am J Cancer Res 2026;16(5):1883-1906. (Full text, PDF)
Zhao Liu, Xiaojie Li, Zhaoxing Li: A novel integrated inflammation response score (IIRS) for predicting all-cause and cardiovascular mortality among cancer survivors. Am J Cancer Res 2026;16(5):1907-1921. (Full text, PDF)
Kaixuan Chen, Jinshao Tang, Huabin Ye, Ying Ye, Rong Tang, Hui Zeng, Minghua Zou: Impact of axillary management approaches on postoperative complication rates in breast cancer and exploration of targeted prevention strategies. Am J Cancer Res 2026;16(5):1922-1939. (Full text, PDF)
Min Yi, Kai Zheng, Hui Ma, Yajie Chen, Yunfeng Tang: Neoadjuvant chemotherapy followed by limb-sparing surgery for osteosarcoma: a retrospective cohort study on efficacy, safety, and prognostic factors. Am J Cancer Res 2026;16(5):1940-1950. (Full text, PDF)
Tianjiao Ge, Yunfei Huang, Heng Song, Wenjia Zhang, Meiqi Wang, Zhenchuan Song: Development of a predictive nomogram for perioperative lower extremity deep vein thrombosis in patients with breast cancer and the efficacy of dextran 40 prophylaxis. Am J Cancer Res 2026;16(5):1951-1965. (Full text, PDF)
Zhi-Cheng Guo, Lian Li, Zhang-Neng Yu, Kun-Peng Wang, Dong Li, Jin-Ting Jiang, Fan He, Li-Tian Zhang, Jia-Wu Yan, Liang-Liang Xu, Hua Zhang, Ming Zhang: Preoperative nomogram for predicting microvascular invasion and stratifying recurrence risk in early-stage hepatocellular carcinoma. Am J Cancer Res 2026;16(5):1966-1976. (Full text, PDF)
Yongzhen Sun, Jingfeng He, Xiaolan Luo, Guangsheng Sun, Xuefang Tao, Weiwei Gan: Construction and validation of a prognostic prediction model for critically ill lung cancer patients based on respiratory functional reserve and systemic inflammatory characteristics. Am J Cancer Res 2026;16(5):1977-2009. (Full text, PDF)
Qun Li, Xiaomeng Cai: Clinical-pathological characteristics and prognosis of elderly primary liver cancer patients. Am J Cancer Res 2026;16(5):2010-2024. (Full text, PDF)
Chuanbing Liu, Zhen Jia, Dan Wei, Huanjun Wang: BANF1 knockdown impedes thyroid cancer development and boosts CD8+ T cell activity through PI3K/AKT/mTOR pathway. Am J Cancer Res 2026;16(5):2025-2039. (Full text, PDF)
Yu Zhou, Yufan Mao, Xueliang Fu, Yanan Li, Meng Xu, Deliang Zhou, Shuai Zha: Schisandrin A suppresses hepatocellular carcinoma and sensitizes to sorafenib via modulating retinol metabolism. Am J Cancer Res 2026;16(5):2040-2054. (Full text, PDF, Supplementary Table 1)
Youhou Zhu, Shuai Wang, Haixin Chen, Yangyang Wang, Binsheng You: Cerebrospinal fluid cellular and inflammatory profiles in tumor-related postoperative infections: influencing factors and clinical features in oncological patients. Am J Cancer Res 2026;16(5):2055-2079. (Full text, PDF)
Guiwen Shao, Jianfei Liu: Drug-eluting beads transarterial chemoembolization improves tumor response and survival compared with conventional TACE in intermediate-stage hepatocellular carcinoma: a retrospective cohort study. Am J Cancer Res 2026;16(5):2080-2092. (Full text, PDF)
Katherine J Young, Zijun Y Xu-Monette: A novel therapeutic avenue: pharmacological induction of tumor cell pyroptosis. Am J Cancer Res 2026;16(5):2093-2096. (Full text, PDF)
Xiao-Qing Guan, Xiao-Ning Yuan, Kai-Xiang Feng, You-Cheng Shao, Qin Liu, Ze-Lin Yang, Yan-Yan Chen, Jin Deng, Mei-Shun Hu, Jun Li, Yi-Hao Tian, Meng-Fei Chu, Jing-Wei Zhang, Lei Wei: IGF2BP2-modified UBE2D1 Interacts with Smad2/3 to Promote the Progression of Breast Cancer: Am J Cancer Res. 2023; 13(7): 2948-2968. Am J Cancer Res 2026;16(5):2097-2099. (Full text, PDF)
Yuanyuan Lyu, Yuhan Wang, Huafeng Ding, Peiling Li: Hypoxia-induced m6A demethylase ALKBH5 promotes ovarian cancer tumorigenicity by decreasing methylation of the lncRNA RMRP: Am J Cancer Res. 2023; 13(9): 4179-4191. Am J Cancer Res 2026;16(5):2100-2101. (Full text, PDF)
Doan Huu Nhat Binh, Tzu-Chun Cheng, Shih-Hsin Tu, You-Cheng Liao, Yi-Yuan Yang, Li-Ching Chen, Yuan-Soon Ho: StAR-related lipid transfer domain protein 3 (STARD3) regulates HER2 and promotes HER2-positive breast cancer progression through interaction with HSP90 and SRC signaling: Am J Cancer Res. 2023; 13(11): 5151-5173. Am J Cancer Res 2026;16(5):2102-2107. (Full text, PDF)
Retraction: microRNA-454 shows anti-angiogenic and anti-metastatic activity in pancreatic ductal adenocarcinoma by targeting LRP6. Am J Cancer Res 2026;16(5):2108. (Full text, PDF)
